| [Establishment of Animal Model of A Human Lung Adenocarcinoma Drug-resistant Cell Line Anip973/NVB and Investigation on Mechanism of Drug Resistance]. | |
| | |
MedLine Citation:
|
PMID: 22429577 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Multidrug resistance (MDR) is the main cause of chemotherapeutic failure in lung cancer, and vinorelbine (NVB) is one of the most efficient drugs that threaten non-small cell lung cancer (NSCLC). The current study aims to establish tumor xenografts and investigate the molecular mechanisms involved in the resistance of NVB in lung adenocarcinoma. METHODS: Nude mice were implanted with Anip973 and Anip973/NVB, and tumor-bearing mice were divided into the Anip973 treatment, Anip973 control, Anip973/NVB treatment, and Anip973/NVB control groups, respectively. The current study observes tumor growth, draws growth curves, and calculates inhibitory rates. The morphological changes in cell tumor were observed through the immunohistochemical method using an electron microscope to detect the expressions of MRP3 and Bcl-2 and to investigate the molecular mechanisms of Anip973/NVB cells. RESULTS: The tumor inhibitory rates of the Anip973 and Anip973/NVB cells treated with NVB were 60.00% and 4.65%, respectively, compared with the control group. The growth inhibition in the Anip973/NVB cell transplantation tumor had no significant difference. Apoptosis was observed using TEM when the Anip973 transplantation tumor was treated with NVB. On the other hand, no apoptosis was found in the Anip973/NVB transplantation tumor using TEM. Immunohistochemical staining (SP) shows the positive expressions of Bcl-2 and MRP3 proteins in Anip973/NVB transplantation tumor, which were observed to be higher than those in the Anip973 transplantation tumor. CONCLUSIONS: The overexpression of Bcl-2 and MRP3 might be one of the major mechanisms of the MDR of Anip973/NVB. |
| | |
Authors:
|
Meng Wang; Xuan Hong; Qinwen Sun; Ruilin Li; Zhaoyang Yang; Gongyan Chen |
Publication Detail:
|
Type: English Abstract; Journal Article |
Journal Detail:
|
Title: Zhongguo fei ai za zhi = Chinese journal of lung cancer Volume: 15 ISSN: 1999-6187 ISO Abbreviation: Zhongguo Fei Ai Za Zhi Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-03-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101126433 Medline TA: Zhongguo Fei Ai Za Zhi Country: China |
Other Details:
|
Languages: chi Pagination: 146-51 Citation Subset: IM |
Affiliation:
|
Department of Medical Oncology, the Third Affiliated Hospital of Harbin Medical University, Harbin 150081, China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Lentivirus-mediated Stable Silencing of nm23-H1 Gene in Lung Cancer Cells ?and the Influence on Bio...
Next Document: [Establishment of the Cell Line that Human Lung Adenocarcinoma can Stably Express Luciferase Which i...